|
||
FOR IMMEDIATE RELEASE ALS/MND Global Awareness Day Unites Leaders in Scientific Research, Clinical
Care June 19, 2013 – The ALS Association Golden West Chapter is joining forces with the International Alliance of ALS/MND Associations for ALS/MND Global Awareness Day. Outside the United States, amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig’s Disease, is called motor neuron disease (MND). Regardless of geographic location, this disease can strike anyone at any time of life without consideration of race, ethnicity, gender, or socioeconomic background. At any given time, there are as many as 30,000 people in the US living with ALS. To date, The ALS Association has committed more than $67 million to find effective treatments and a cure. This investment has already increased the number of scientists around the world studying the disease and has helped to yield critical new discoveries including new insights into the complex genetic and environmental factors that are associated with it. “Scientific research, coupled with clinical studies and the highest quality of care for people with ALS will serve as the means for realizing our vision to create a world where ALS no longer robs unsuspecting individuals of their ability to walk, talk and eventually to breathe,” said Fred Fisher, The Golden West Chapter’s President and CEO. “Finding more effective treatments, and ultimately a cure for ALS, is very much a global effort.” In honor of Lou Gehrig’s birthday on June 19 and ALS/MND Global Awareness Day on June 21, The ALS Association Golden West Chapter is calling on the ALS community to show their support and help raise awareness for this fatal disease in one of the following ways:
About ALS/MND ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Eventually, people with ALS lose the ability to initiate and control muscle movement, which often leads to total paralysis and death within two to five years of diagnosis. For unknown reasons, veterans are twice as likely to develop ALS as the general population. There is no cure, and only one drug approved by the U.S. Food and Drug Administration modestly extends survival.
About The ALS Association and The Golden West Chapter |
|
||
FOR IMMEDIATE RELEASE ALS/MND Global Awareness Day Unites Leaders in Scientific Research, Clinical
Care June 19, 2013 – The ALS Association Golden West Chapter is joining forces with the International Alliance of ALS/MND Associations for ALS/MND Global Awareness Day. Outside the United States, amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig’s Disease, is called motor neuron disease (MND). Regardless of geographic location, this disease can strike anyone at any time of life without consideration of race, ethnicity, gender, or socioeconomic background. At any given time, there are as many as 30,000 people in the US living with ALS. To date, The ALS Association has committed more than $67 million to find effective treatments and a cure. This investment has already increased the number of scientists around the world studying the disease and has helped to yield critical new discoveries including new insights into the complex genetic and environmental factors that are associated with it. “Scientific research, coupled with clinical studies and the highest quality of care for people with ALS will serve as the means for realizing our vision to create a world where ALS no longer robs unsuspecting individuals of their ability to walk, talk and eventually to breathe,” said Fred Fisher, The Golden West Chapter’s President and CEO. “Finding more effective treatments, and ultimately a cure for ALS, is very much a global effort.” In honor of Lou Gehrig’s birthday on June 19 and ALS/MND Global Awareness Day on June 21, The ALS Association Golden West Chapter is calling on the ALS community to show their support and help raise awareness for this fatal disease in one of the following ways:
About ALS/MND ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Eventually, people with ALS lose the ability to initiate and control muscle movement, which often leads to total paralysis and death within two to five years of diagnosis. For unknown reasons, veterans are twice as likely to develop ALS as the general population. There is no cure, and only one drug approved by the U.S. Food and Drug Administration modestly extends survival.
About The ALS Association and The Golden West Chapter |